Guidelines for the use of economic evaluation to inform policies around access to treatment for kidney failure

Hariharan, S., Israni, A. K. & Danovitch, G. Long-term survival after kidney transplantation. N. Engl. J. Med. 385, 729–743 (2021).

Article  CAS  PubMed  Google Scholar 

Himmelfarb, J., Vanholder, R., Mehrotra, R. & Tonelli, M. The current and future landscape of dialysis. Nat. Rev. Nephrol. 16, 573–585 (2020).

Article  PubMed  PubMed Central  Google Scholar 

Thurlow, J. S. et al. Global epidemiology of end-stage kidney disease and disparities in kidney replacement therapy. Am. J. Nephrol. 52, 98–107 (2021).

Article  PubMed  Google Scholar 

Harris, D. C. H. et al. Increasing access to integrated ESKD care as part of universal health coverage. Kidney Int. 95, S1–S33 (2019).

Article  PubMed  Google Scholar 

Francis, A. et al. Chronic kidney disease and the global public health agenda: an international consensus. Nat. Rev. Nephrol. 20, 473–485 (2024).

Article  PubMed  Google Scholar 

Liyanage, T. et al. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet 385, 1975–1982 (2015).

Article  PubMed  Google Scholar 

Lunney, M. et al. Availability, accessibility, and quality of conservative kidney management worldwide. Clin. J. Am. Soc. Nephrol. 16, 79–87 (2021).

Article  Google Scholar 

Kaur, G. et al. Cost of hemodialysis in a public sector tertiary hospital of India. Clin. Kidney J. 11, 726–733 (2018).

Article  PubMed  PubMed Central  Google Scholar 

Ashuntantang, G. et al. Outcomes in adults and children with end-stage kidney disease requiring dialysis in sub-Saharan Africa: a systematic review. Lancet Glob. Health 5, e408–e417 (2017).

Article  PubMed  Google Scholar 

Olowu, W. A. et al. Outcomes of acute kidney injury in children and adults in sub-Saharan Africa: a systematic review. Lancet Glob. Health 4, e242–e250 (2016).

Article  PubMed  Google Scholar 

Jamison, D. T. et al. Disease Control Priorities: Improving Health and Reducing Poverty. 3rd edn Vol. 9 (World Bank, 2017); https://doi.org/10.1596/978-1-4648-0527-1.

Teerawattananon, Y., Dabak, S. V., Khoe, L. C., Bayani, D. B. S. & Isaranuwatchai, W. To include or not include: renal dialysis policy in the era of universal health coverage. BMJ 368, m82 (2020).

Article  PubMed  PubMed Central  Google Scholar 

Luyckx, V. A., Miljeteig, I., Ejigu, A. M. & Moosa, M. R. Ethical challenges in the provision of dialysis in resource-constrained environments. Semin. Nephrol. 37, 273–286 (2017).

Article  PubMed  Google Scholar 

Okpechi, I. G. et al. Building optimal and sustainable kidney care in low resource settings: the role of healthcare systems. Nephrology 26, 948–960 (2021).

Article  PubMed  Google Scholar 

Katz, I. J., Gerntholtz, T. & Naicker, S. Africa and nephrology: the forgotten continent. Nephron Clin. Pract. 117, 320–327 (2010).

Article  Google Scholar 

Van Biesen, W. et al. Considerations on equity in management of end-stage kidney disease in low- and middle-income countries. Kidney Int. Suppl. 10, e63–e71 (2020).

Article  Google Scholar 

Drummond, M. F., Sculpher, M. J., Claxton, K., Stoddart, G. L., Torrance, G. W. Methods for the Economic Evaluation of Health Care Programmes. Oxford Univ. Press2015.

Google Scholar 

World Health Organization. 2015 Global Survey on Health Technology Assessment by National Authorities: Main Findings. https://iris.who.int/bitstream/handle/10665/375063/9789241509749-eng.pdf?sequence=1 (2015).

Kim, D. D. et al. Developing criteria for health economic quality evaluation tool. Value Health 26, 1225–1234 (2023).

Article  PubMed  Google Scholar 

Caro, J. J., Briggs, A. H., Siebert, U. & Kuntz, K. M. Modeling good research practices — overview: a report of the ISPOR-SMDM modeling good research practices task force-1. Value Health 15, 796–803 (2012).

Article  PubMed  Google Scholar 

Edwards, R. T. & McIntosh, E. (eds). Applied Health Economics for Public Health Practice and Research (Oxford Univ. Press, 2019); https://doi.org/10.1093/med/9780198737483.001.0001.

Meltzer, M. I. Introduction to health economics for physicians. Lancet 358, 993–998 (2001).

Article  CAS  PubMed  Google Scholar 

Roberts, M. et al. Conceptualizing a model: a report of the ISPOR-SMDM modeling good research practices task force-2. Value Health 15, 804–811 (2012).

Article  PubMed  PubMed Central  Google Scholar 

Davies, M. & Cassimjee, Z. Provision of long-term renal replacement therapy to non-national patients in South Africa. South. Afr. Med. J. 111, 615 (2021).

Article  CAS  Google Scholar 

Thaweethamcharoen, T., Sritippayawan, S., Noparatayaporn, P. & Aiyasanon, N. Cost-utility analysis of continuous ambulatory peritoneal dialysis and automated peritoneal dialysis for Thai patients with end-stage renal disease. Value Health Reg. Issues 21, 181–187 (2020).

Article  PubMed  Google Scholar 

Bayani, D. B. S. et al. Filtering for the best policy: an economic evaluation of policy options for kidney replacement coverage in the Philippines. Nephrology 26, 170–177 (2021).

Article  PubMed  Google Scholar 

Li, B. et al. Equity–efficiency trade-offs associated with alternative approaches to deceased donor kidney allocation: a patient-level simulation. Transplantation 104, 795–803 (2020).

Article  PubMed  PubMed Central  Google Scholar 

Spinowitz, B. et al. Economic and quality of life burden of anemia on patients with CKD on dialysis: a systematic review. J. Med. Econ. 22, 593–604 (2019).

Article  PubMed  Google Scholar 

Gupta, D. et al. Peritoneal dialysis — first initiative in India: a cost-effectiveness analysis. Clin. Kidney J. 15, 128–135 (2022).

Article  PubMed  Google Scholar 

Erbe, A. W., Kendzia, D., Busink, E., Carroll, S. & Aas, E. Value of an integrated home dialysis model in the United Kingdom: a cost-effectiveness analysis. Value Health 26, 984–994 (2023).

Article  PubMed  Google Scholar 

Chalkidou, K., Culyer, A. J. & Nemzoff, C. Perspective in Economic Evaluations of Health Care Interventions in Low- and Middle-Income Countries — One Size Does Not Fit All. https://www.cgdev.org/sites/default/files/perspective-economic-evaluations-healthcare-interventions-low-and-middle-income.pdf (Center for Global Development, 2018).

Sittimart, M. et al. An overview of the perspectives used in health economic evaluations. Cost. Eff. Resour. Alloc.22, 41 (2024).

Article  PubMed  PubMed Central  Google Scholar 

Drummond, M. et al. Transferability of economic evaluations across jurisdictions: ISPOR good research practices task force report. Value Health 12, 409–418 (2009).

Article  PubMed  Google Scholar 

Sassi, F. Calculating QALYs, comparing QALY and DALY calculations. Health Policy Plan. 21, 402–408 (2006).

Article  PubMed  Google Scholar 

Donnelly, J. Comparative effectiveness research (updated). Health Aff. (Millwood) https://doi.org/10.1377/hpb20101008.552571 (2010).

Rand, L. Z. & Kesselheim, A. S. Controversy over using quality-adjusted life-years in cost-effectiveness analyses: a systematic literature review. Health Aff. 40, 1402–1410 (2021).

Article  Google Scholar 

Beresniak, A. et al. Validation of the underlying assumptions of the quality-adjusted life-years outcome: results from the ECHOUTCOME European project. Pharmacoeconomics 33, 61–69 (2015).

Article  PubMed  Google Scholar 

Anand, S. & Hanson, K. Disability-adjusted life years: a critical review. J. Health Econ. 16, 685–702 (1997).

Article  CAS  PubMed  Google Scholar 

Tomeny, E. M. et al. Rethinking tuberculosis morbidity quantification: a systematic review and critical appraisal of TB disability weights in cost-effectiveness analyses. Pharmacoeconomics 42, 1209–1236 (2024).

Article  PubMed  PubMed Central  Google Scholar 

Arnesen, T. & Nord, E. The value of DALY life: problems with ethics and validity of disability adjusted life years. BMJ 319, 1423–1425 (1999).

Article  CAS 

Comments (0)

No login
gif